Reduction of cytotoxicity to normal tissues by new regimens of cell-cycle phase-specific drugs
From MaRDI portal
Publication:1109704
DOI10.1016/0025-5564(88)90002-8zbMath0655.92004MaRDI QIDQ1109704
Zvia Agur, R. Arnon, B. Schechter
Publication date: 1988
Published in: Mathematical Biosciences (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/0025-5564(88)90002-8
chemotherapy; cell-cycle length; cell-cycle phase-specific drugs; cytosine arabinoside; leukemic cell line; minimizing cytotoxicity to normal tissues; period of drug application; short drug pulses
Related Items
USING COMPUTER SIMULATIONS FOR EVALUATING THE EFFICACY OF BREAST CANCER CHEMOTHERAPY PROTOCOLS, LONG-RANGE PREDICTABILITY IN MODELS OF CELL POPULATIONS SUBJECTED TO PHASE-SPECIFIC DRUGS: GROWTH-RATE APPROXIMATION USING PROPERTIES OF POSITIVE COMPACT OPERATORS, A mathematical model of in vitro cancer cell growth and treatment with the antimitotic agent curacin \(A\), Optimal controls for a model with pharmacokinetics maximizing bone marrow in cancer chemo\-therapy, A theoretical analysis of interval drug dosing for cell-cycle-phase- specific drugs, A mathematical model to study the effects of drug resistance and vasculature on the response of solid tumors to chemotherapy, Optimal control for a stochastic model of cancer chemotherapy, Tumour eradication by antiangiogenic therapy: analysis and extensions of the model by Hahnfeldt et al. (1999), A mathematical model of cycle-specific chemotherapy, A mathematical model of periodically pulsed chemotherapy: Tumor recurrence and metastasis in a competitive environment, THREE TYPES OF SIMPLE DDE'S DESCRIBING TUMOR GROWTH
Cites Work
- The effect of environmental disturbances on the dynamics of marine intertidal populations
- Mathematical model of cancer chemotherapy. Periodic schedules of phase- specific cytotoxic-agent administration increasing the selectivity of therapy
- Estimation and prediction of cell cycle specific effects of anticancer drugs
